Exelixis Inc (EXEL :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
EXEL FEATURED NEWS & ANALYSIS
MORE FROM OUR PARTNERS
-
Exelixis And Cabozantinib: ASCO 2013 Highlights 07 Jun 2013 - Seeking Alpha
-
3 Innovative Biotech Companies With Promising Cancer Therapies 29 May 2013 - Seeking Alpha
-
Exelixis Prepares For ASCO 2013, Stock Stays Rangebound 24 May 2013 - Seeking Alpha
LATEST TRANSCRIPTS
-
Exelixis' Goldman Sachs 34th Annual Global Healthcare Conference - Tra... 12 Jun 2013 - Seeking Alpha
-
Exelixis CEO Presents at UBS Global Healthcare Conference (Transcript) 21 May 2013 - Seeking Alpha
PRESS RELEASES
-
Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of ... 11 Jun 2013 - PR Newswire
-
Exelixis Announces Webcasts of Upcoming Investor Conference Presentati... 05 Jun 2013 - Business Wire
-
For Second- and Subsequent-Line Metastatic Castrate-Resistant Prostate... 05 Jun 2013 - PR Newswire
-
Exelixis Presents COMETRIQ(TM) (cabozantinib) Clinical Trial Data in P... 02 Jun 2013 - Business Wire
-
Exelixis Announces Presentation of Updated Phase 2 Data for Cabozantin... 01 Jun 2013 - Business Wire
-
Exelixis Initiates Phase 3 Pivotal Trial of Cabozantinib in Patients W... 31 May 2013 - Business Wire
